Division of Internal Medicine, Botucatu School of Medicine, University of São Paulo State (UNESP). Botucatu, Sao paulo, Brazil.
Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK; Department of Nephrology, Royal Free London NHS Foundation Trust, London, UK.
Semin Nephrol. 2023 Sep;43(5):151467. doi: 10.1016/j.semnephrol.2023.151467. Epub 2024 Jan 9.
Infections are the second leading cause of death among patients with end-stage kidney disease, behind only cardiovascular disease. In addition, patients on chronic dialysis are at a higher risk for acquiring infection caused by multidrug-resistant organisms and for death resulting from infection owing to their likelihood of requiring treatment that involves invasive devices, their frequent exposure to antibiotics, and their impaired immunity. Vascular access is a major risk factor for bacteremia, hospitalization, and mortality among hemodialysis (HD) patients. Catheter-related bacteremia is the most severe central venous catheter (CVC)-related infection and increases linearly with the duration of catheter use. Given the high prevalence of CVC use and its direct association with catheter-related bacteremia, which adversely impacts morbidity and mortality rates among HD patients, several prevention measures aimed at reducing the rates of CVC-related infection have been proposed and implemented. As a result, a large number of clinical trials, systematic reviews, and meta-analyses have been conducted to assess the effectiveness, clinical applicability, and long-term adverse effects of such measures. Peritoneal dialysis chronic treatment without the occurence of peritonitis is rare. Although most cases of peritonitis can be treated adequately with antibiotics, some cases are complicated by hospitalization or a temporary or permanent need to abstain from using the peritoneal dialysis catheter. Severe and long-lasting peritonitis can lead to peritoneal membrane failure, requiring the treatment method to be switched to HD. Some measures as patients training, early diagnosis, and choice of antibiotics can contribute to the successful treatment of peritonitis. Finally, medical directors are key leaders in infection prevention and are an important resource to implement programs to monitor and improve infection prevention practices at all levels within the dialysis clinic.
在终末期肾病患者中,感染是仅次于心血管疾病的第二大致死原因。此外,慢性透析患者由于需要接受涉及侵入性器械的治疗、经常接触抗生素以及免疫功能受损,因此更容易感染多药耐药菌,并因感染而死亡。血管通路是血液透析(HD)患者发生菌血症、住院和死亡的一个主要危险因素。导管相关菌血症是最严重的中心静脉导管(CVC)相关感染,并且随着导管使用时间的延长而呈线性增加。鉴于 CVC 的高使用率及其与导管相关菌血症的直接关联,这会对 HD 患者的发病率和死亡率产生不利影响,因此已经提出并实施了多项旨在降低 CVC 相关感染率的预防措施。因此,已经进行了大量的临床试验、系统评价和荟萃分析,以评估这些措施的有效性、临床适用性和长期不良影响。腹膜透析慢性治疗不发生腹膜炎的情况很少见。虽然大多数腹膜炎病例可以通过抗生素充分治疗,但有些病例会因住院或暂时或永久需要停止使用腹膜透析导管而变得复杂。严重和持久的腹膜炎可导致腹膜膜衰竭,需要切换到 HD 治疗。一些措施,如患者培训、早期诊断和抗生素选择,可以有助于成功治疗腹膜炎。最后,医疗主任是感染预防的关键领导者,是在透析诊所各级实施监测和改进感染预防实践计划的重要资源。